Biotech Small Cap Stocks
Discover investment opportunities in Biotech Small Cap Stocks using our Smart AI Filter.
AI is processing your request...
AI is analyzing your request
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Biotech Small Cap Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Biotech Small Cap Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Biotech Small Cap Stocks using our Smart AI Filter.
8 stocks found for "Biotech Small Cap Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
---|---|---|---|---|---|---|
0.70 Risk measure | ±46.8% Price volatility | 1.5 Valuation | 0.00% Annual yield | |||
0.91 Risk measure | ±96.3% Price volatility | -1.4 Valuation | 0.00% Annual yield | |||
2.32 Risk measure | ±96.8% Price volatility | -0.7 Valuation | 0.00% Annual yield | |||
0.90 Risk measure | ±63.6% Price volatility | -4.0 Valuation | 0.00% Annual yield | |||
2.26 Risk measure | ±100.0% Price volatility | -7.6 Valuation | 0.00% Annual yield | |||
2.09 Risk measure | ±91.3% Price volatility | -6.2 Valuation | 0.00% Annual yield | |||
1.01 Risk measure | ±62.0% Price volatility | 25.4 Valuation | 0.00% Annual yield | |||
1.34 Risk measure | ±55.5% Price volatility | -10.4 Valuation | 0.00% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Sarepta plummets after a third death in its muscular dystrophy program for investigational gene therapies, prompts FDA action and intensifies safety scrutiny.
Read moreVir Biotechnology (VIR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Read moreFate Therapeutics (FATE) reported earnings 30 days ago. What's next for the stock?
Read moreOn CNBC's 'Mad Money Lightning Round,' Jim Cramer recommended buying Dover Corporation DOV.
Read moreKaryopharm Therapeutics (KPTI) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Read moreBluebird Bio (BLUE) came out with a quarterly loss of $2.66 per share versus the Zacks Consensus Estimate of a loss of $3.60. This compares to loss of $7.20 per share a year ago.
Read more